FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and pharmaceutical industry. Medication for prevention of bird flu of mammals includes as active component oxidised dextran with molecular weight 35-60 kDa in concentration 0.4-4.0 wt % in pharmaceutically acceptable solvent. As pharmaceutically acceptable solvent it includes water for injections or physiological solution or physiologically acceptable buffer solution.
EFFECT: invention ensures increase of preventive action efficiency.
2 cl, 3 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR INFLUENZA PREVENTION | 2014 |
|
RU2572332C1 |
| INTRANASAL DRUG FOR INFLUENZA PREVENTION | 2017 |
|
RU2634250C1 |
| MEANS FOR PREVENTION OF INTERSTITIAL PNEUMONIA | 2020 |
|
RU2747550C1 |
| COMPOSITION HAVING IMMUNOSTIMULATING ACTION FOR SUBLINGUAL ADMINISTRATION | 2017 |
|
RU2647455C1 |
| METHODS OF PREVENTION AND TREATMENT OF DISEASES CAUSED BY A/H5N1 BIRD INFLUENZA VIRUS WITH USING INTERFERON INDUCER AND NEURAMINIDASE INHIBITOR | 2008 |
|
RU2398596C2 |
| METHOD OF PREVENTING DISEASE CAUSED BY AVIAN FLU VIRUS | 2008 |
|
RU2395295C2 |
| PHARMACEUTICAL COMPOSITION BASED ON HERBAL EXTRACTS FOR TREATMENT AND PREVENTION OF VIRAL INFECTIONS AND SYPHILIS AND METHOD OF TREATMENT AND PREVENTION OF VIRAL INFECTIONS AND SYPHILIS | 2009 |
|
RU2401121C1 |
| AGENT FOR VIRUS DISEASES PREVENTION AND TREATMENT AND METHOD OF VIRUS DISEASES PREVENTION AND TREATMENT | 2007 |
|
RU2337703C1 |
| APPLICATION OF ACETYLSALICYLIC ACID SALT FOR TREATMENT OF VIRAL INFECTIONS | 2009 |
|
RU2524304C2 |
| MATERIALS AND METHODS OF TREATING VIRAL INFECTIONS BY MEANS OF CYSTAMINE COMPOUND | 2006 |
|
RU2431476C2 |
